🎉 And it is here! SHL Medical proudly announces our participation in the upcoming events at CPHI Milan, PDA - Parenteral Drug Association Universe, PODD: Partnership Opportunities in Drug Delivery Community News, and PDA APAC - Parenteral Drug Association Aseptic. Our experts will be on-site to discuss the latest industry trends and showcase our innovative solutions, including our Molly® modular platform autoinjectors, Maggie® cartridge-based autoinjectors, and our very first electromechanical autoinjector! ✨ Join our experts in a series of innovation talks, posters, and podium presentations and engage in insightful discussions at our booths and tabletops to explore our vertically integrated manufacturing capabilities, global expansion, sustainability initiatives, and more! These events are a fantastic opportunity for us to connect with other pharma professionals and deepen our understanding to better support our partners in delivering life-saving solutions to patients. Check out the comment ⬇️ for more details of our participations. We’re very much pumped for October – hope to see you there! #CPHI2024 #PODD2024 #PDAUniverse2024 #PDAAseptic2024
SHL Medical
Medizintechnik
SHL Medical is a world-leading designer, developer, and manufacturer of drug delivery solutions such as autoinjectors.
Info
SHL Medical is a world-leading solutions provider of advanced drug delivery systems, such as autoinjectors. Driven by our company purpose – Enabling Patients’ Independence, we partner with leading pharma and biotech companies to pioneer the development of patient-centric solutions that support the enhancement of patients’ quality of life through self-injection systems as well as digital healthcare solutions. With over 5,000 employees located across our Switzerland, USA, Sweden and Taiwan offices, we rely on our comprehensive in-house manufacturing capabilities to provide end-to-end services, from design, development to final assembly, labeling, and packaging.
- Website
-
https://www.shl-medical.com
Externer Link zu SHL Medical
- Branche
- Medizintechnik
- Größe
- 5.001–10.000 Beschäftigte
- Hauptsitz
- Zug
- Art
- Privatunternehmen
- Gegründet
- 1989
- Spezialgebiete
- Medical Device Manufacturing, Design and Development of Auto Injectors and Pen Injectors, Molding, CNC Machining, Metrology, Automation, Assembly und Final Assembly
Orte
Beschäftigte von SHL Medical
Updates
-
As the global leader in self-injection solutions, ensuring device performance for patients of all body types is our top priority. At SHL Medical, we tackle this challenge by developing testing methods that simulate real-life injection scenarios. Discover how we assess autoinjector activation by joining Eric Linvill’s presentation on September 10 at 10:50 AM JST, where he’ll showcase how we use silicone models with varying stiffness and surface properties to mimic human tissue. By refining our understanding of how autoinjectors interact with the body, we’re committed to delivering smooth, reliable injections every time. Ready to join us in Tokyo for this year’s Prefilled Syringe Seminar? 🌟 #ThoughtLeadership #DrugDelivery #PFSSTokyo
-
Calling all future leaders and innovators! Are you ready for your next big step? As a pioneer in self-injection solutions, SHL Medical is committed to enabling patients’ independence. We are improving their experience by: 🤝 Partnering with leading pharma and biotech companies 💡 Developing high-quality and #innovative solutions 🙌 Empowering millions of patients worldwide ✨ Generating positive impact across healthcare system Explore opportunities with us – where passion meets purpose – and be part of a team that shapes the future of the #drugdelivery industry. https://lnkd.in/epRV-eAN #ExcellenceCulture #Career
-
Did you know there is an increasing prevalence of cardiometabolic conditions like heart disease, type 2 diabetes, and #obesity? World Health Organization estimated over a billion people are affected by obesity worldwide, contributing to the rise of cardiometabolic diseases. To this end, self-injection devices are becoming essential to manage these conditions at home, improving convenience and treatment compliance. SHL Medical stands at the forefront of this movement. In 2023 alone, we supported 1.6 million cardiometabolic patients with over 40 million devices. SHL’s latest article in the Pharmaceutical Manufacturing and Packaging Sourcer magazine Samedan Ltd. delves further into the advancements of innovative solutions such as our Molly® autoinjectors to support the rapidly growing cardiometabolic care market. Download and read the full article 📝 https://lnkd.in/gYVBYzMH #CardiometabolicCare #DrugDelivery #Innovation
-
A new #SustainabilityAtSHL post is here. Get ready to be inspired, informed, and empowered! 💪 In our 2023 sustainability report, SHL Medical is bringing to life our 2030 Sustainability Strategy. The strategy – which includes driving patient health and independence, reducing ecological footprint, and ensuring responsible business practices across our value chain – set a series of ambitious targets to reinforce our sustainability efforts at large. Our sustainable journey is fueled by passion for meaningful progress through concrete actions, as showcased by our achievements in 2023. Every step we take is driven by our commitment to creating a better world for future generations. Download the full report https://shorturl.at/vNqTF to delve deeper into our dedication in building a more sustainable future. 💚 #SustainabilityJourney #ImpactfulProgress
-
At SHL Medical, we pride ourselves on fostering a dynamic workplace that blends diverse perspectives and talents, driving our success through cultural synergy. In an interview with the Trade Office of Swiss Industries, SHL Medical Taiwan’s General Manager Sebastian Feng shared his insights on our success in harmonizing the business cultures of Taiwan and Switzerland, both of which value problem-solving and accountability. Operating as #OneSHL, we unify our efforts to ensure effective collaborations and continuous improvement, positioning us as a truly global and forward-thinking company. As we continue to grow, we are on the lookout for talented individuals to join our team. If you are driven by innovation and aspire to make a meaningful impact, SHL Medical is your destination. Apply today at 💼 https://bit.ly/3M9ItTK and start your own SHL story. #GlobalImpact #Career #HiringNow
-
-
💫 In-line quality inspection for SMART The challenges in quality control for fully automated assembly systems, such as SMART – the Semi-Modular Automatic Robot Track – lies in the mass amount of components being assembled at the same time. 🎛️ Built with integrated, hi-tech vision systems, probes and/or laser sensors, the SMART’s in-line quality control measures ensure that components are within specifications and assembled with accuracy. The high-precision in the detection, measurement, and monitoring of all activities help to ensure production quality and final product reliability. Check the article on ONdrugDelivery to gain an understanding of SMART’s quality inspection measures: https://bit.ly/4dHlET1 #Innovation #DrugDelivery #ThoughtLeadership
-
How does SHL Medical lead the future of cardiometabolic care? Lars Berger highlighted SHL’s commitment in driving the next wave of cardiometabolic care. We have been at the forefront of this movement. With more than 30 years of industry experience and 50 combination products under our belt, we have been supporting our pharma partners in delivering life-changing solutions to patients worldwide. Since 2015, we have supported the launch of six combination products indicated for cardiometabolic diseases, improving the lives of at least 1.6 million patients afflicted with hyperlipidaemia, type 2 diabetes, and obesity. More on SHL’s successes in enabling patients’ independence ➡️ https://bit.ly/3M4ELKV #CardiometabolicCare #ThoughtLeadership #DrugDelivery
Leading the charge in cardiometabolic care
-
The Asia-Pacific region is one of the largest pre-filled syringe markets by volume, with Japan as a key contributor. This year’s PFSS Tokyo offers an excellent platform for SHL Medical to enhance our leadership in this rapidly growing market. Aside from networking with other industry leaders and staying ahead of regulatory trends, SHL’s Eric Linvill, PhD will present our research on autoinjector activation on human soft tissue, further demonstrating our commitment to patient-centric innovations. Have a project in mind? Drop by Tabletop #13 between Sep 10-11 in Sola City Conference Center, Tokyo to find out how we can assist you. More on our participation: https://bit.ly/3Mo98fH #DrugDelivery #JoinUs
-
-
🔥 🧩 We are well on the way to an exciting new chapter at our North Charleston facility in the US! Today we’re celebrating a major milestone as we produced our very first pallet! This achievement is truly a testament to our team’s dedication and commitment to sustainable #innovation. And as we continue to embark on this incredible journey, we are also looking to fill our team with talented individuals to help us shape the future of #drugdelivery. Apply today https://bit.ly/4fB44Sm and take your career to new heights! #Career #HiringNow